Related Experiment Video
Updated: Jun 13, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Visual Impairment at Presentation in Pediatric Uveitis: A Multicentric Study in 477 Children Across Southern and
Shabtab Nasir1, Mohammed Hasnat Ali2, Anamika Patel3,4
1Saroja A Rao Center for Uveitis, LV Prasad Eye Institute, Hyderabad, India.
Objective:
To evaluate visual impairment (VI) at presentation in pediatric uveitis cases in southern and eastern India.
Methods:
Retrospective analysis of 477 children across four tertiary centers (2015-2020). Best-documented visual acuity (ETDRS letters) in the better eye was used to categorize VI.
Results:
Mean age at presentation was 11 ± 3.7 years; 43.8% were females, and 64.8% bilateral. Of 205 patients with complete investigations, 32.7% were undifferentiated uveitis, 31.7% infectious, 25.7% juvenile idiopathic arthritis-associated uveitis, and 10.2% other non-infectious uveitis. At presentation, 79.0% had none to mild VI, 12.6% moderate VI, and 8.4% severe VI to blindness. On generalized estimating equations analysis for individual eyes, prior oral steroids and older age were risk factors, while female gender, prior topical corticosteroids and immunosuppressive therapy were protective against moderate and/or severe VI.
Conclusions:
Over a fifth of pediatric uveitis cases present with moderate/severe VI, especially in older age or with prior oral corticosteroid therapy.
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview

